January 22, 2024 – Our CEO, Tom Congdon, took center stage at the OBN BioSeed event, a prestigious gathering connecting biotech innovators with investors. Highlighting our company’s advancements and vision in cryobiology, Tom’s presentation aimed to secure vital financial backing, critical for our ongoing research and development efforts.

The BioSeed event, known for fostering growth in the biotech sector, served as an ideal platform for discussing future breakthroughs and exploring investment opportunities. Our participation reflects a strategic step towards strengthening our financial base, ensuring we continue to lead in cryobiology innovations.

This initiative aligns with our broader strategy to advance scientific research in cryobiology, promising to unlock new therapies and technologies. With the interest garnered at BioSeed, we are poised to forge ahead in our mission, backed by a stronger network of supporters and investors.